Donepezil MSAD Study Investigators Group. A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease - Feldman,H.; Gauthier,S.; Hecker,J.; Vellas,B.; Subbiah,P.; Whalen,E. (Neurology, 2001)